Conjugate Vaccine Immunotherapy for Substance Use Disorder.

about

Investigations into the efficacy of multi-component cocaine vaccines.Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.Molecular Genetics and New Medication Strategies for Opioid Addiction

P2860

Q47216341-6830D230-D0F0-47DB-9E3B-457352EE29E0 Q52317280-B8340599-BC1E-4511-AEF0-6C73883D7A73 Q57133609-B2B2B47C-0F10-437C-ACB7-C6C8D27C457F

P2860

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

Item

http://www.wikidata.org/entity/Q39387013

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@en

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@nl

type

Item

label

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@en

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@nl

prefLabel

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@en

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@nl

P1476

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

@en

P2093

Kim D Janda

http://www.w3.org/2001/XMLSchema#string

Paul T Bremer

http://www.w3.org/2001/XMLSchema#string

P2860

Trace amines: identification of a family of mammalian G protein-coupled receptors

A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats

Gout-associated uric acid crystals activate the NALP3 inflammasome

Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial

Vaccine pharmacotherapy for the treatment of cocaine dependence

Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

Sequence analysis of peptides bound to MHC class II molecules

P304

298-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/PR.117.013904

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28634286

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

substance P

P932

5482184

http://www.w3.org/2001/XMLSchema#string

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

about

P2860

P2860

Conjugate Vaccine Immunotherapy for Substance Use Disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932